InvestorsHub Logo
Followers 13
Posts 1599
Boards Moderated 0
Alias Born 12/14/2016

Re: None

Monday, 08/07/2017 3:42:01 PM

Monday, August 07, 2017 3:42:01 PM

Post# of 144823
Mr Waggoner on the appointee of DR Scher;

“Not only will Dr. Sher be a key member of the senior management team, she will oversee our entire clinical research program. Dr. Sher has been the Principal or Co-Principal Investigator on more than 50 clinical trials. This experience is invaluable to PharmaCyte. Dr. Sher is expected to contribute considerably to our success as a biotech company and, most importantly, to a successful pivotal trial in pancreatic cancer.”

- She will oversee the research program

- She has been involved in over 50 trials

-Why would such a distinguished, credible Dr agree to work at PharmaCyte? Because she wants to be part of something huge, cure people of deadly diseases, meet an unmet medical need!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News